Filana Therapeutics, Inc.
Filana Therapeutics, Inc. scores highest on Torque (67) and lowest on Nitro (15). Its PosiPenta is 40.75 out of 100, around the middle of similar companies.
On the Penta Grid this week, Filana Therapeutics, Inc. is Grid #515 of 837 in the Healthcare sector in United States, and Grid #2,817 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Filana Therapeutics, Inc. | 40.75 | 45 | 53 | 15 | 67 | 25 |
| Estrella Immunopharma, Inc. | 41.19 | 0 | 42 | 21 | 88 | 55 |
| BioStem Technologies, Inc. | 51.71 | 79 | 46 | 25 | 49 | 60 |
| Metagenomi Therapeutics, Inc. | 38.59 | 49 | 34 | 17 | 39 | 55 |
| Impact BioMedical Inc. | 61.00 | 75 | 96 | 20 | 72 | 42 |
| Aligos Therapeutics, Inc. | 34.56 | 40 | 27 | 34 | 37 | 35 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.82 |
| P/B ratio | 0.53 |
EEarnings
| Trailing EPS | ₹-81.45 |
| Forward EPS | — |
NNitro
| Price | 66.63 |
| 52-week high | 444.21 |
| 52-week low | 63.46 |
| Fall from 52-week high | 85.0% |
TTorque
| Return on equity (ROE) | -55.78% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | -0.66 |
| Market cap | ₹321 Cr |
| Insider holding | 2.05% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Filana Therapeutics, Inc.'s PosiPenta score?
Filana Therapeutics, Inc.'s PosiPenta is 40.75 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Filana Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Filana Therapeutics, Inc. is Grid #515 of 837 in the Healthcare sector in United States, and Grid #2,817 of 4,000 in United States.
Which PosiPenta pillar is strongest for Filana Therapeutics, Inc.?
Torque (durability), with a score of 67 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Filana Therapeutics, Inc.?
Nitro (momentum), with a score of 15 out of 100: much weaker than most similar companies.
Has Filana Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.77 points, from 36.98 to 40.75.
PositoAI is for research and education only and is not investment advice.